Epperly Melissa B, has filed 26 insider transactions across 3 companies since June 2023.
Most recent transaction: a sale of 41861 shares of Roivant Sciences Ltd. ($ROIV) on March 16, 2026.
Activity breakdown: 0 open-market purchases and 3 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 16, 2026 | Roivant Sciences Ltd. | $ROIV | Epperly Melissa B, | Director | S | Common Shares | 41861 | $28.68 | 15,804.0000 | 696,859,682 | 72.59% | 0.01% |
| Jan. 20, 2026 | Roivant Sciences Ltd. | $ROIV | Epperly Melissa B, | Not found | F | Common Shares | 54 | $22.98 | 57,665.0000 | 696,859,682 | 0.09% | 0.00% |
| Jan. 20, 2026 | Roivant Sciences Ltd. | $ROIV | Epperly Melissa B, | Not found | A | Common Shares | 815 | $0.00 | 57,719.0000 | 696,859,682 | 1.43% | 0.00% |
| Oct. 20, 2025 | Roivant Sciences Ltd. | $ROIV | Epperly Melissa B, | Not found | A | Common Shares | 1056 | $0.00 | 56,904.0000 | 680,947,866 | 1.89% | 0.00% |
| Sept. 10, 2025 | Roivant Sciences Ltd. | $ROIV | Epperly Melissa B, | Not found | A | Stock Option (Right to Buy) | 33726 | $0.00 | 33,726.0000 | 725,395,624 | 9999.99% | 0.00% |
| Sept. 10, 2025 | Roivant Sciences Ltd. | $ROIV | Epperly Melissa B, | Not found | J | Common Shares | 1661 | $13.77 | 55,848.0000 | 725,395,624 | 2.89% | 0.00% |
| Sept. 10, 2025 | Roivant Sciences Ltd. | $ROIV | Epperly Melissa B, | Not found | A | Common Shares | 14524 | $0.00 | 57,509.0000 | 725,395,624 | 33.79% | 0.00% |
| July 17, 2025 | Roivant Sciences Ltd. | $ROIV | Epperly Melissa B, | Not found | A | Common Shares | 1609 | $0.00 | 42,985.0000 | 725,395,624 | 3.89% | 0.00% |
| June 23, 2025 | Nautilus Biotechnology, Inc. | $NAUT | Epperly Melissa B, | Director | A | Stock Option (Right to Buy) | 45000 | $0.00 | 45,000.0000 | 126,148,469 | 9999.99% | 0.04% |
| April 17, 2025 | Roivant Sciences Ltd. | $ROIV | Epperly Melissa B, | Not found | A | Common Shares | 1847 | $0.00 | 41,376.0000 | 725,395,624 | 4.67% | 0.00% |
| Jan. 23, 2025 | Roivant Sciences Ltd. | $ROIV | Epperly Melissa B, | Not found | F | Common Shares | 180 | $11.21 | 39,529.0000 | 731,318,202 | 0.45% | 0.00% |
| Jan. 23, 2025 | Roivant Sciences Ltd. | $ROIV | Epperly Melissa B, | Not found | A | Common Shares | 1672 | $0.00 | 39,709.0000 | 731,318,202 | 4.40% | 0.00% |
| Oct. 21, 2024 | Roivant Sciences Ltd. | $ROIV | Epperly Melissa B, | Not found | A | Common Shares | 1613 | $0.00 | 38,037.0000 | 735,642,721 | 4.43% | 0.00% |
| Sept. 12, 2024 | Roivant Sciences Ltd. | $ROIV | Epperly Melissa B, | Not found | J | Common Shares | 4245 | $12.12 | 36,424.0000 | 831,049,444 | 10.44% | 0.00% |
| Sept. 10, 2024 | Roivant Sciences Ltd. | $ROIV | Epperly Melissa B, | Not found | A | Stock Option (Right to Buy) | 27894 | $0.00 | 27,894.0000 | 831,049,444 | 9999.99% | 0.00% |
| Sept. 10, 2024 | Roivant Sciences Ltd. | $ROIV | Epperly Melissa B, | Not found | A | Common Shares | 16406 | $0.00 | 40,669.0000 | 831,049,444 | 67.62% | 0.00% |
| July 23, 2024 | Roivant Sciences Ltd. | $ROIV | Epperly Melissa B, | Not found | A | Common Shares | 1702 | $0.00 | 24,263.0000 | 831,049,444 | 7.54% | 0.00% |
| June 14, 2024 | Nautilus Biotechnology, Inc. | $NAUT | Epperly Melissa B, | Director | A | Stock Option (Right to Buy) | 45000 | $0.00 | 45,000.0000 | 0 | 9999.99% | 0.00% |
| April 24, 2024 | Roivant Sciences Ltd. | $ROIV | Epperly Melissa B, | Not found | F | Common Shares | 123 | $10.90 | 22,561.0000 | 831,049,444 | 0.54% | 0.00% |
| April 24, 2024 | Roivant Sciences Ltd. | $ROIV | Epperly Melissa B, | Not found | A | Common Shares | 1146 | $0.00 | 22,684.0000 | 831,049,444 | 5.32% | 0.00% |
| Feb. 12, 2024 | Zentalis Pharmaceuticals, Inc. | $ZNTL | Epperly Melissa B, | Chief Financial Officer | S | Common Stock | 2573 | $11.44 | 451,449.0000 | 0 | 0.57% | 0.00% |
| Feb. 1, 2024 | Zentalis Pharmaceuticals, Inc. | $ZNTL | Epperly Melissa B, | Chief Financial Officer | A | Stock Option (Right to Buy) | 75000 | $0.00 | 75,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 2, 2024 | Zentalis Pharmaceuticals, Inc. | $ZNTL | Epperly Melissa B, | Chief Financial Officer | S | Common Stock | 8669 | $11.54 | 454,022.0000 | 0 | 1.87% | 0.00% |
| Feb. 1, 2024 | Zentalis Pharmaceuticals, Inc. | $ZNTL | Epperly Melissa B, | Chief Financial Officer | A | Common Stock | 75000 | $0.00 | 462,691.0000 | 0 | 19.35% | 0.00% |
| Jan. 19, 2024 | Roivant Sciences Ltd. | $ROIV | Epperly Melissa B, | Not found | A | Common Shares | 1207 | $0.00 | 21,538.0000 | 712,791,115 | 5.94% | 0.00% |
| June 15, 2023 | Nautilus Biotechnology, Inc. | $NAUT | Epperly Melissa B, | Director | A | Stock Option (Right to Buy) | 45000 | $0.00 | 45,000.0000 | 0 | 9999.99% | 0.00% |